跳至主要内容
临床试验/NCT05406778
NCT05406778已完成不适用

SPARK Neuro Quantitative Resting State EEG Protocol for Assessing Cognitive Impairment and Alzheimer's Disease Status- The REMIND Study

Spark Neuro Inc.14 个研究点 分布在 1 个国家目标入组 185 人开始时间: 2022年5月18日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
185
试验地点
14
主要终点
EEG Data collection for AI software development

研究概览

简要总结

The study utilizes investigational software, the SPARK Test, with an FDA-cleared electroencephalography (EEG) amplifier and EEG cap to collect and patient EEG data.

详细描述

The aim of this study is to collect data to support development of an algorithm to determine whether applying machine-learning techniques to eyes open/eyes closed resting-state electroencephalography (EEG) can characterize patient's cognitive status and detect the presence or absence of AD on the basis of the patient's EEG.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Diagnostic
盲法
None

入排标准

年龄范围
55 Years 至 85 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age 55 to 85 at the time of consent
  • Informant available and willing (remotely or in-person) to provide information about sleep patterns and cognitive functioning who spends >8 hours per week with primary subject
  • Subject or Legally Authorized Representative (LAR) has the ability to provide informed consent and comply with the protocol.

排除标准

  • Unable to remain still for up to 30 minutes during EEG data recording
  • Subjects currently on and unable to wash out concomitant medications, including: 1) opiates; 2) benzodiazepines and nonbenzodiazepine hypnotics; 3) sedative antihistamines; 4) tricyclic anti-depressants; 5) skeletal muscle relaxants; 6) antiepileptics; 7) antipsychotics; 8) antimanic agents; 9) THC; 10) anticholinergics
  • Previous history of craniotomy
  • Medical or psychiatric illness that would interfere with study participation
  • History of epilepsy or chronic seizure disorder
  • Presence of non-dental metal in head
  • Currently experiencing a skin disease on scalp that would affect electrode contacts
  • Subject meets at least one of the following criteria:
  • Diagnosis of cognitive impairment from various underlying pathologies as indicated by one of the diagnostic codes listed in Appendix A (protocol)
  • MMSE score of 27 or less
  • Treating physician or PI have documented that the patient is cognitively impaired, with judgment of cognitive impairment having been made within the 6 months prior to enrollment
  • Substance Use Disorder, including Alcohol

结局指标

主要结局

EEG Data collection for AI software development

时间窗: During the diagnostic procedure

Rate of complete software collection per enrolled subjects complete a SPARK Test recording.

次要结局

未报告次要终点

研究者

发起方
Spark Neuro Inc.
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验